life sciences & healthcare:
R&D partners

Life sciences in Cambridge is built on intellectual entrepreneurialism and the collaboration between our research community – a nexus of ground-breaking research institutions and world leading hospitals, all with strong links to the private sector.

Life sciences in Cambridge is built on intellectual entrepreneurialism and the collaboration between our research community – a nexus of ground-breaking research institutions and world leading hospitals, all with strong links to the private sector.

The Cambridge life sciences cluster is globally unique in its geographic concentration of world-class capabilities—a truly extraordinary entrepreneurial community where research, industry, and health join forces to tackle the biggest healthcare challenges facing the world today

Laurel Powers-Freeling
Chair, Cambridge University Health Partners

The Cambridge life sciences cluster is globally unique in its geographic concentration of world-class capabilities—a truly extraordinary entrepreneurial community where research, industry, and health join forces to tackle the biggest healthcare challenges facing the world today

Laurel Powers-Freeling
Chair, Cambridge University Health Partners

Home to over 20 Nobel Prize winners in life sciences since 2000, the University of Cambridge underpins the knowledge engine for the surrounding cluster. Further, the region has benefited from significant investment in critical research base initiatives such as the MRC Laboratory of Molecular Biology, Wellcome Sanger Institute, , CRUK Cambridge Institute and EMBL European Bioinformatics Institute.

200% +

The number of new companies ‘born’ in the cluster more than doubled between 2018-19 and 2019-20, from 64 to 138

The concentration of expertise in Cambridge has resulted in the leadership of national initiatives, including the NIHR BioResource and Health Data Research UK. These have allowed the UK to take a world-leading role in advanced therapies, data science and genomics. Three highly-respected NHS Trusts work with industry to translate innovation into patient benefit, hosting the largest National Institute for Health Research (NIHR) Biomedical Research Centre in the UK.

Productive interactions between industry scientists, clinicians and academics are facilitated through state-of-the-art research infrastructure and multiple science and technology parks. As such, public sector investment in the East of England currently leverages over four times the amount of investment from business R&D, representing the highest ratio in the UK.

In Cambridge, opportunity is everywhere. It is a place where scientists, businesses, clinicians and entrepreneurs converge to co-create the transformative therapies of the future.

Kathryn Chapman, University Enterprise Zone, University of Cambridge

View Life sciences & healthcare champions

Notable recent highlights

Cambridge Immunity Experimental Medicine Unit

The proposed Immunity Experimental Medicine Unit (iEMU) will enable human experimental medicine studies into COVID-19, accelerating the delivery of vaccines, antivirals and other therapies to the clinic. The proposal is supported by GlaxoSmithKline and AstraZeneca and will play a key part of supporting the pharmaceutical and biotechnology industries.

PerkinElmer acquires Horizon Discovery

Read press release


Sanofi completes Kymab acquisition

Read press release

Life Sciences and Healthcare

A world class cluster across biotechnology, pharmaceuticals, medtech and everything in between

Find out more

Cambridge& is here to help

Harriet Fear MBE

A warm welcome to Cambridge&. We look forward to working with you in accessing the Greater Cambridge ecosystem, to support your plans for locating, partnering and/or scaling here. Cambridge is a safe place to do risky things – for the good of the world.

If you would like to discuss anything please send me a message through the form or give me a call on +44 (0) 7555 297622

Best wishes
Harriet

Harriet Fear MBE
Director
Cambridge&